Add to Basket
Order hotline:
![]() |
+1 404 474 4654 |
![]() |
+1 888 205 9894 (TF) |
DUSP1 (C-Term) antibody
| Antigen | DUSP1 (C-Term) |
| Clonality | Polyclonal |
| Host |
Alternatives Rabbit |
| Reactivity |
Alternatives Human |
| Application |
Alternatives Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
|
| Catalog no. | ABIN337195 |
| Quantity | 50 µg (1 mg/ml) (Variants) |
| Price | 466.67 $ Plus shipping costs $35.00 |
| Shipping to |
|
| Availability | Ships within 10 to 15 Business Days |
Additional Information
| Swiss-Prot | P28562 |
| Immunogen | Synthetic peptide, KLH-conjugated, synthetic peptide corresponding to amino acids 87-101 (DERSAALDGAKRDGT-C) of human MAP kinase phosphatase 1 (MKP1), with a C-terminal cysteine added for conjugation purposes. The immunizing sequence is identical in rat and mouse. |
| Isotype | IgG (Matching secondary antibodies) |
| Description | Gene: DUSP1, Standard Gene Symbol: DUSP1, Family: Protein Phosphatase, Subfamily: Dual specificity MKP, Synonyms: DUSP1, 3CH134, CL100, Dual specificity phosphatase 1, ERK-inactivating phosphatase, HVH1, Map kinase phosphatase 1, Mitogen-activated kinase phosphatase-1, MKP-1, MKP1, PTPN10, VH1 |
| Specificity | Recognizes human MKP1, Mr ~42kD. Species cross-reactivity: mouse. Predicted to cross-react with rat based on sequence homology. Predicted Reactivities: Mouse (Murine). |
Application Details
| Application Notes | IHC-P (5 µg/ml), WB (0.1 - 1 µg/ml) |
| Concentration | 1 mg/ml |
| Purification | Protein A Column |
| Buffer | 0.1 M Tris-glycine, pH 7.4, 0.15 M sodium chloride, 0.05% sodium azide, before the addition of glycerol to 30% |
| Storage | +4°C or -20°C, Avoid repeated freezing and thawing. |
| Restrictions | For Research Use only |
Images
Alternatives
Alternatives for antigen "DUSP1 (C-Term)", type "Antibodies"
| Hosts | Rabbit (2), Goat (1) |
| Reactivities | Human (3) |
| Applications | ELISA (3), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (2), Western Blotting (WB) (2) |




Alternatives